市場調查報告書

全球心房纖維顫動手術市場:成長,趨勢,及預測(2020年∼2025年)

Atrial Fibrillation Surgery Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921859
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
全球心房纖維顫動手術市場:成長,趨勢,及預測(2020年∼2025年) Atrial Fibrillation Surgery Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

心臟病是世界上主要的死亡原因,生活方式的改變以及壓力和肥胖症的發生在迅速增加罹患心臟病的人數。隨著心臟病病例數的增加,心房顫動的病例數也增加,同時高昂的治療費用給各國經濟帶來沉重負擔,是市場成長主要因素。

本報告提供全球心房纖維顫動手術市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,產品·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 肥胖的增加率
    • 心臟病治療費負擔的增加
    • 提高國民意識的計劃增加
  • 市場阻礙因素
    • 治療的高成本
    • 設備相關的法規問題
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 心導管電氣燒灼術
    • 外科的切除
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Boston Scientific Corporation
    • Medtronic Plc
    • Biotronik
    • AtriCure, Inc.
    • Cardiofocus, Inc.
    • Abbott Laboratories
    • Advansta, Inc.

第7章 市場機會及今後趨勢

目錄
Product Code: 67135

Market Overview

The market studied is majorly driven by the factor such as the rising prevalence of obesity and the growing burden of heart diseases across the globe. It has been indicated by the World Health Organization that obesity has been tripled in the world since 1975. Statistics from WHO suggest that during the year 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of these over 650 million were obese. This accounts for 39% of adults being overweight and 13% among them being obese. During the year 2016, around 41 million children below age 5 years were obese or overweight.

In addition, heart diseases are the major cause of death across the globe and due to the changing lifestyle and stress, the number of people suffering from heart diseases is increasing rapidly. Due to the growing cases of heart patients, there is a rise in the number of cases of atrial fibrillation and this is posing a high burden of the economies of various countries as the cost of treatment is higher. Hence, owing to the aforementioned statements, the market studied is expected to grow in the forecast period.

Scope of the Report

As per the scope of the report, atrial fibrillation (AF) is a common abnormal heart rhythm that occurs when electrical impulses fire off from different places in the atria (the top chambers of the heart) in a disorganized way. The market is segmented by product, end-user, and geography.

Key Market Trends

Ambulatory Surgical Center Segment is expected to be the Fastest-Growing Segment over the Forecast Period

The ambulatory surgical center segment is expected to be the fastest-growing segment owing to the enhanced healthcare infrastructure, availability of skilled labor, and affordability. The rise in patient pool, owing to substantial growth in the geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, is expected to enhance revenue generations. Moreover, compared to conventional surgeries, the benefits of minimally invasive surgeries such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time are encouraging more patients to opt for MIS surgeries, which is expected to boost the market growth.

Furthermore, due to the rising burden of obesity, there is an increase in the number of people suffering from atrial fibrillation among such a population. Hence, it is believed that an increased prevalence of obesity is contributing to the growth of the market.

The United States Holds the Largest Share of the Market

The United States holds the largest share of the atrial fibrillation market. This is majorly attributed to a large number of people suffering from this disease in the country and the presence of key players. As per the statistics provide by the CDC (Centre for Disease Control and Prevention), there are around 2.7-6.1 million people in the United States have AFib and with the rising geriatric population, it is expected that this number will grow in the future. High blood pressure which is one of the leading causes of atrial fibrillation accounts for around 14% to 22% of all AFib cases in the country.

With the presence of key players in the country and availability of favorable insurance policies, people across the country are able to get the surgery done at low costs which are augmenting the growth of the market studied in the United States.

Competitive Landscape

The market for atrial fibrillation is moderately competitive and consists of local as well as global companies. Most of the developed countries are being dominated by international players whereas, developing countries are witnessing the penetration of new entrants in the market. With the technological advancements and the focus of developing economies on improving the healthcare system, it is expected that more companies will enter the market and hold a substantial share in the future.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Obesity
    • 4.2.2 Increased Burden of Heart Diseases
    • 4.2.3 Rising Number of Programs to Enhance Public Awareness
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Procedure
    • 4.3.2 Regulatory Issues Associated with the Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Catheter Ablation
    • 5.1.2 Surgical Ablation
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Medtronic Plc
    • 6.1.3 Biotronik
    • 6.1.4 AtriCure, Inc.
    • 6.1.5 Cardiofocus, Inc.
    • 6.1.6 Abbott Laboratories
    • 6.1.7 Advansta, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS